Methyl 3-chloro-4-(piperazin-1-yl)benzoate, 98%, 250mg

Acide L(+)-ascorbique, min 99 %, pa, 250 g, emballage plastique.

Atazanavir Sulfate>98.0%(HPLC)100mg

4-(6-((Methylsulfonyl)oxy)benzo[b]thiophen-2-yl)phenyl methanesulfonate, 95+%, 1g

2-(Trifluoromethyl)benzeneboronic acid, 95.0%, 1g

(4'-(Trifluoromethyl)-[1,1'-biphenyl]-4-yl)boronic acid, 98%, 250mg

Fmoc-�-HoVal-OH, 95%, 250mg

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]thiourea, 97%, 100mg

7-Chloro-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid, 97+%, 1g

2-Bromo-5-iodopyridin-4-amine, 98%, 5g

Maleic Acid Monoamide>98.0%(HPLC)(T)25g

Methyl Tiglate>98.0%(GC)25mL

Methyl 4-amino-3-hydroxybenzoate, 95.0%, 100g